A RANDOMIZED CLINICAL TRIAL OF EARLY CONVERSION FROM TACROLIMUS TO EVEROLIMUS IN DECEASED DONOR KIDNEY TRANSPLANTATION

被引:0
|
作者
Pacheco e Silva, Alvaro
Tonato, Eduardo
Durao, Marcelino, Jr.
Requiao-Moura, Lucio
Arruda, Erika
Chinen, Rogerio
Filliponi, Thiago
Melo, Luciana
Matos, Ana
机构
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
引用
收藏
页码:277 / 278
页数:2
相关论文
共 50 条
  • [31] The Impact of Extended Release Tacrolimus and Everolimus Based Immunosuppressive Regimen on Living Donor Kidney Transplantation
    Hiramitsu, Takahisa
    Futamura, Kenta
    Okada, Manabu
    Goto, Norihiko
    Ichimori, Toshihiro
    Narumi, Shunji
    Watarai, Yoshihiko
    TRANSPLANTATION, 2022, 106 (09) : S105 - S105
  • [32] Donor Specific Antibodies after Conversion from Mycophenolate Mofetil with Standard Exposure Tacrolimus to Everolimus with Tacrolimus Minimization in Stable Kidney Transplanted Recipients
    Luisa Rodriquez-Ferrero, Maira
    Hurtado, Esther
    Alenda, Raquel
    Garcia-Sanchez, Felix
    Balas, Antonio
    Luis Vicario, Jose
    Anaya, Fernando
    TRANSPLANTATION, 2018, 102 : S586 - S586
  • [33] Everolimus with Reduced Tacrolimus (EVR/rTAC) Maintains Efficacy Following Living Donor Liver Transplantation (LDLT): An International Randomized Trial
    Jeng, L. -B.
    Lee, Gyu S.
    Soin, A. S.
    Lee, W. -C.
    Yoshizumi, T.
    Lopez, P.
    Kochuparampil, J.
    Sips, C.
    Kaneko, S.
    Grant, D.
    TRANSPLANTATION, 2017, 101 (05) : 376 - 377
  • [34] Clinical pancreas transplantation from deceased donor in Japan
    Kenmochi, Takashi
    Ito, Toshinori
    Nakajima, Ichiro
    TRANSPLANTATION, 2016, 100 (07) : S13 - S13
  • [35] A Randomized Controlled Clinical Trial Comparing Belatacept With Tacrolimus After De Novo Kidney Transplantation
    de Graav, Gretchen N.
    Baan, Carla C.
    Clahsen-van Groningen, Marian C.
    Kraaijeveld, Rens
    Dieterich, Marjolein
    Verschoor, Wenda
    von der Thusen, Jan H.
    Roelen, Dave L.
    Cadogan, Monique
    van de Wetering, Jacqueline
    van Rosmalen, Joost
    Weimar, Wilem
    Hesselink, Dennis A.
    TRANSPLANTATION, 2017, 101 (10) : 2571 - 2581
  • [36] Clinical Experience of Tacrolimus With Everolimus in Heart Transplantation
    Wang, S. -S.
    Chou, N. -K.
    Chi, N. -H.
    Huang, S. -C.
    Wu, I. -H.
    Wang, C. -H.
    Yu, H. -Y.
    Chen, Y. -S.
    Tsao, C. -I.
    Ko, W. -J.
    Shun, C. -T.
    TRANSPLANTATION PROCEEDINGS, 2012, 44 (04) : 907 - 909
  • [37] Everolimus plus early tacrolimus minimization: a phase III, randomized, open-label, multicentre trial in renal transplantation
    Langer, Robert M.
    Hene, Ronald
    Vitko, Stefan
    Christiaans, Maarten
    Tedesco-Silva, Helio, Jr.
    Ciechanowski, Kazimierz
    Cassuto, Elisabeth
    Rostaing, Lionel
    Vilatoba, Mario
    Machein, Uwe
    Ulbricht, Bettina
    Junge, Guido
    Dong, Gaohong
    Pascual, Julio
    TRANSPLANT INTERNATIONAL, 2012, 25 (05) : 592 - 602
  • [38] Early Conversion to Everolimus Within 180 Days of Living Donor Liver Transplantation
    Rudzik, Katelyn N.
    Schonder, Kristine S.
    Humar, Abhinav
    Johnson, Heather J.
    CLINICAL TRANSPLANTATION, 2024, 38 (07)
  • [39] The ischemic preconditioning paradox in deceased donor liver transplantation-evidence from a prospective randomized single blind clinical trial
    Koneru, B.
    Shareef, A.
    Dikdan, G.
    Desai, K.
    Klein, K. M.
    Peng, B.
    Wachsberg, R. H.
    de la Torre, A. N.
    Debroy, M.
    Fisher, A.
    Wilson, D. J.
    Samanta, A. K.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 (12) : 2788 - 2796
  • [40] Blood transfusion in deceased donor kidney transplantation
    Marzouk, Karim
    Lawen, Joseph
    Kiberd, Bryce A.
    TRANSPLANTATION RESEARCH, 2013, 2